Metastasis review: from bench to bedside
- PMID: 25104089
- DOI: 10.1007/s13277-014-2421-z
Metastasis review: from bench to bedside
Abstract
Cancer is the final result of uninhibited cell growth that involves an enormous group of associated diseases. One major aspect of cancer is when cells attack adjacent components of the body and spread to other organs, named metastasis, which is the major cause of cancer-related mortality. In developing this process, metastatic cells must successfully negotiate a series of complex steps, including dissociation, invasion, intravasation, extravasation, and dormancy regulated by various signaling pathways. In this review, we will focus on the recent studies and collect a comprehensive encyclopedia in molecular basis of metastasis, and then we will discuss some new potential therapeutics which target the metastasis pathways. Understanding the new aspects on molecular mechanisms and signaling pathways controlling tumor cell metastasis is critical for the development of therapeutic strategies for cancer patients that would be valuable for researchers in both fields of molecular and clinical oncology.
Similar articles
-
From bench to bedside: does preclinical practice in translational oncology need some rebuilding?J Natl Cancer Inst. 2013 Oct 2;105(19):1426-7. doi: 10.1093/jnci/djt253. Epub 2013 Sep 19. J Natl Cancer Inst. 2013. PMID: 24052623 No abstract available.
-
Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.Sci China Life Sci. 2016 Oct;59(10):1057-1062. doi: 10.1007/s11427-012-4398-4. Sci China Life Sci. 2016. PMID: 23132500 No abstract available.
-
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.Oncotarget. 2016 Nov 15;7(46):76337-76353. doi: 10.18632/oncotarget.10942. Oncotarget. 2016. PMID: 27486983 Free PMC article. Review.
-
TGF-β signaling in cancer metastasis.Acta Biochim Biophys Sin (Shanghai). 2018 Jan 1;50(1):121-132. doi: 10.1093/abbs/gmx123. Acta Biochim Biophys Sin (Shanghai). 2018. PMID: 29190313 Review.
-
[Targeted based therapies in metastatic breast cancer: future evolution].Therapie. 2012 Nov-Dec;67(6):491-503. doi: 10.2515/therapie/2012068. Epub 2012 Dec 19. Therapie. 2012. PMID: 23249575 Review. French.
Cited by
-
Telomerase reverse transcriptase activates transcription of miR500A to inhibit Hedgehog signalling and promote cell invasiveness.Mol Oncol. 2021 Jul;15(7):1818-1834. doi: 10.1002/1878-0261.12943. Epub 2021 May 2. Mol Oncol. 2021. PMID: 33713376 Free PMC article.
-
Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.Tumour Biol. 2016 Oct;37(10):13059-13075. doi: 10.1007/s13277-016-5294-5. Epub 2016 Aug 26. Tumour Biol. 2016. PMID: 27561758 Review.
-
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma.Sci Rep. 2021 Mar 9;11(1):5496. doi: 10.1038/s41598-021-84185-x. Sci Rep. 2021. PMID: 33750814 Free PMC article.
-
Oleic acid induces migration through a FFAR1/4, EGFR and AKT-dependent pathway in breast cancer cells.Endocr Connect. 2019 Mar;8(3):252-265. doi: 10.1530/EC-18-0543. Endocr Connect. 2019. PMID: 30721135 Free PMC article.
-
Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway.Oncol Lett. 2018 Mar;15(3):2939-2945. doi: 10.3892/ol.2017.7699. Epub 2017 Dec 28. Oncol Lett. 2018. PMID: 29435022 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources